In re the Grand Jury Subpoena June 12, 1986

658 F. Supp. 387, 1986 U.S. Dist. LEXIS 16281
CourtDistrict Court, D. Maryland
DecidedDecember 18, 1986
DocketMisc. No. N-86-2126
StatusPublished

This text of 658 F. Supp. 387 (In re the Grand Jury Subpoena June 12, 1986) is published on Counsel Stack Legal Research, covering District Court, D. Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re the Grand Jury Subpoena June 12, 1986, 658 F. Supp. 387, 1986 U.S. Dist. LEXIS 16281 (D. Md. 1986).

Opinion

MEMORANDUM

NORTHROP, Senior District Judge.

By order dated October 3, 1986, this Court denied a motion to quash1 and ordered a certain corporation2 (“the corporation”) engaged in the manufacture of prescription drugs to comply with a subpoena duces tecum issued by the grand jury in the District of Maryland and directed to the corporation. The order of October 3rd, commanded the corporation to begin producing a portion of the subpoenaed documents within 30 days of that date. On October 29,1986 pursuant to Fed.R.Crim.P. 17(c) the corporation filed a renewed motion to quash the grand jury subpoena on a ground not raised in its earlier motion, contending that the subpoena violates the Fifth Amendment’s prohibition against compelled self-incrimination.

After a careful review of the pleadings submitted by the parties in this case, the Court finds that no hearing is necessary. Local Rule 6. For the reasons set out below the corporation’s renewed motion to quash will be denied.

The subpoenaed corporation is a business involved in the manufacture, production and distribution of generic prescription drugs. Stock in the company is held by four shareholders. The company’s founder and president (“the president”) owns 97 per cent of the stock while three of his children each own one per cent. Carl Turner, a Food and Drug Administration Compliance officer familiar with the operation of the corporation, estimated, in an affidavit, that the subpoenaed corporation has a gross income in excess of $50,000,000 and employs over 100 employees.

In August of 1985, the United States Government filed a civil suit against the corporation, its president and another indi[389]*389vidual alleging violations of the Federal Food, Drug and Cosmetic Act. This suit was resolved on November 4, 1985 when the parties entered into a consent decree of permanent injunction which enjoined the defendants from introducing or delivering for introduction into interstate commerce any drug manufactured, processed, packed, labeled or held at the plant unless and until all such procedures were conducted in conformity with good manufacturing practice regulations. In the consent decree, the defendants agreed to maintain a variety of records relating to the manufacture and distribution of these drugs and to make these documents available to the Food and Drug Administration (FDA) for inspection and copying.

On June 12, 1986, the grand jury in the District of Maryland issued a subpoena duces tecum to the corporation in furtherance of an investigation of illegal practices in the manufacture of prescription drugs. The subpoena sought the production of sixteen categories of documents relating to the corporation’s production and distribution of certain drugs, most of which were prepared by the corporation’s manufacturing and quality control personnel during the period of 1983-1985.3 The corporation has estimated that the subpoena would require the production of approximately one million documents.

Service of the subpoena was effected on July 24, 1986 when it was delivered to an accountant employed by the corporation. The subpoena is directed solely to the corporation itself. The definition section of the subpoena makes clear, however, that where a paragraph of the subpoena refers to the corporation by name this request encompasses relevant records prepared, not only by the corporation and a second specified company, but also those generated by “all affiliated predecessor and successor corporations, partnerships and other legal entities, and all officers, agents, servants, employees and/or consultants in active concert or participation with any of the foregoing who are acting for such companies or entities, wherever located.”

In the presently pending renewed motion to quash, the president of the subpoenaed corporation claims that he is entitled to assert a fifth amendment privilege against self incrimination as to the subpoenaed documents and the act of producing them. The Court must first consider whether the president of the corporation may avail himself of the protection afforded by this privilege.

It is well settled fifth amendment jurisprudence that the privilege against compulsory self incrimination “is essentially a personal one, applying only to natural individuals.” United States v. White, 322 U.S. 694, 698, 64 S.Ct. 1248, 1251, 88 L.Ed. 1542 (1944). Thus, although a sole proprietor or sole practitioner may claim the privilege, a collective entity “an organization which is recognized as an independent entity apart from its members”, may not. Bellis v. United States, 417 U.S. 85, 88-89, 92, 94 S.Ct. 2179, 2182-2183, 2185, 40 L.Ed.2d 678 (1974).

Since a corporation, as a collective entity, has no Fifth Amendment privilege of its own, the Supreme Court has repeatedly held that when a subpoena seeks corporate records, an individual may not assert a Fifth Amendment privilege to avoid producing potentially incriminating corporate records which are in his possession in a representative capacity. Bellis, 94 S.Ct. at 2183. “It is well settled that no privilege can be claimed by the custodian of corporate records, regardless of how small the corporation may be.” Id. at 2189. This rule applies whether the subpoena is addressed to the corporation itself or to an individual in his representative capacity. Wilson v. United States, 221 U.S. 361, 31 S.Ct. 538, 55 L.Ed. 771 (1911) (subpoena [390]*390directed to corporation); Dreier v. United States, 221 U.S. 394, 31 S.Ct. 550, 55 L.Ed. 784 (1911) (subpoena directed to individual corporate officer).

In Bellis, the Supreme Court identified two primary reasons underlying the refusal to allow a corporate representative to claim a Fifth Amendment privilege when corporate documents are requested by the government. First, the Supreme Court has consistently stressed that the Fifth Amendment privilege was designed to protect individuals and was not meant to restrict valid governmental regulation of economic entities. “The framers of the constitutional guarantee against compulsory self disclosure, who were interested in protecting individual civil liberties, cannot be said to have intended the privilege to be available to protect economic or other interests of such organizations so as to nullify appropriate government regulations.” Id. 417 U.S. at 92, 94 S.Ct. at 2184, quoting United States v. White, 322 U.S. at 700, 64 S.Ct. at 1251. In view of that fact that corporate records can be produced only through the acts of its of agents or officers, the Court recognized that granting a Fifth Amendment privilege to such individuals would undermine the rule that a corporation cannot claim the privilege and “largely frustrate legitimate governmental regulation of such organizations.” Bellis, 417 U.S. at 91, 94 S.Ct. at 2184.

The second basis for the rule rested upon the privacy rationale often ascribed to the Fifth Amendment privilege. Traditional Fifth Amendment analysis held that the privilege was conceived in order to ensure that an individual’s privacy remain sacrosanct.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Dreier v. United States
221 U.S. 394 (Supreme Court, 1911)
United States v. White
322 U.S. 694 (Supreme Court, 1944)
Couch v. United States
409 U.S. 322 (Supreme Court, 1973)
Bellis v. United States
417 U.S. 85 (Supreme Court, 1974)
Fisher v. United States
425 U.S. 391 (Supreme Court, 1976)
United States v. Doe
465 U.S. 605 (Supreme Court, 1984)
In Re Grand Jury Subpoena Duces Tecum Served Upon
781 F.2d 64 (Sixth Circuit, 1986)
In Re Grand Jury Subpoena (85-W-71-5)
784 F.2d 857 (Eighth Circuit, 1986)
Wilson v. United States
221 U.S. 361 (Supreme Court, 1911)
Fox v. Rothensies
115 F.2d 42 (Third Circuit, 1940)
In Re Grand Jury Subpoena Duces Tecum (Doe)
605 F. Supp. 174 (E.D. New York, 1985)
United States v. Antonio J. Sancetta, M.D., P.C.
788 F.2d 67 (Second Circuit, 1986)
United States v. Lang
792 F.2d 1235 (Fourth Circuit, 1986)
See v. United States
479 U.S. 811 (Supreme Court, 1986)

Cite This Page — Counsel Stack

Bluebook (online)
658 F. Supp. 387, 1986 U.S. Dist. LEXIS 16281, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-the-grand-jury-subpoena-june-12-1986-mdd-1986.